Marksans Pharma Q1 Results Live : profit rise by 29.27% YOY

Marksans Pharma Q1 Results Live : Marksans Pharma Q1 Results Live : Marksans Pharma declared their Q1 results on 13 Aug, 2024. The topline increased by 18.12% & the profit increased by 29.27% YoY. As compared to the previous quarter the revenue grew by 5.47% and the profit increased by 13.36%.

The Selling, general & administrative expenses rose by 0.92% q-o-q & increased by 17.95% Y-o-Y.

The operating income was up by 21.91% q-o-q & increased by 22.29% Y-o-Y.

The EPS is ₹1.96 for Q1 which increased by 28.95% Y-o-Y.

Marksans Pharma has delivered 7.95% return in the last 1 week, 35.14% return in last 6 months and 33.04% YTD return.

Currently the Marksans Pharma has a market cap of ₹9712.66 Cr and 52wk high/low of ₹217.47 & ₹97.45 respectively.

As of 15 Aug, 2024 out of 1 analysts covering the company, 1 analyst has given Strong Buy rating.

The consensus recommendation as on 15 Aug, 2024 was to Strong Buy.